Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Pasetti is active.

Publication


Featured researches published by M. Pasetti.


Radiotherapy and Oncology | 2008

Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC

Giovanni Mauro Cattaneo; Italo Dell’Oca; Sara Broggi; Claudio Fiorino; Lucia Perna; M. Pasetti; G. Sangalli; Nadia di Muzio; Ferruccio Fazio; Riccardo Calandrino

BACKGROUND AND PURPOSE To investigate the impact of Helical Tomotherapy (HT) upon the dose distribution when compared to our routinely delivered 3D conformal radiotherapy (CRT) in the case of patients affected by stage III non-small-cell lung cancer (NSCLC). MATERIAL AND METHODS Thirteen stage III inoperable NSCLC patients were scheduled to receive 61.2-70.2Gy, 1.8Gy/fraction. Two treatment techniques (HT and CRT) were considered, and in the case of CRT the dose calculation was performed using both the pencil beam (PB) and Anisotropic Analytical Algorithm (AAA) available on the Varian Eclipse planning system. Dose volume constraints for PTV coverage and OAR sparing were assessed for the HT inverse planning with the highest priority upon PTV coverage and spinal cord sparing. The three plans were compared in terms of dose-volume histograms (DVHs) and normal tissue complication probability (NTCP). A statistical analysis was performed using non-parametric Wilcoxon matched pairs tests. RESULTS In CRT the use of a less accurate algorithm (PB) decreased the monitor unit number by 2.4%. HT significantly improved dose homogeneity within PTV compared with CRT_AAA. For lung parenchyma V20-V40 were lower with HT, corresponding to a decrease of 7% in the risk of radiation pneumonitis. The volume of the heart and esophagus irradiated to >45-60Gy were reduced using HT plans. For eight PTs with an esophagus-PTV overlap >5%, HT significantly reduced both late and acute esophageal complication probability. CONCLUSIONS Our findings obtained in stage III NSCLC patients underline that HT guarantees an important sparing of lungs and esophagus, thus HT has the potential to improve therapeutic ratio, when compared with CRT, by means of dose escalation and/or combined treatment strategy. In CRT of locally advanced lung cancers, the use of a more advanced algorithm would give significantly better modeling of target dose and coverage.


Radiotherapy and Oncology | 2016

EP-1725: Predictors of diarrhea after whole-pelvis post-prostatectomy radiotherapy

C. Sini; C. Fiorino; L. Perna; B. Noris Chiorda; V. Sacco; M. Pasetti; A. Chiara; R. Calandrino; N. Di Muzio; C. Cozzarini

S807 ________________________________________________________________________________ was maintained as long as the effect metric used for Cox regression had a linear correlation with the true effect metric of at least 0.50. The conclusions held if the trial cohort consisted of an expected high benefit population (22% reduced sample size), but the effect was even stronger if the cohort was a population with modest expected benefit (31% reduced sample size).


Clinical Oncology | 2016

Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study

N. Di Muzio; A. Fodor; B. Noris Chiorda; S. Broggi; P. Mangili; Riccardo Valdagni; I. Dell'Oca; M. Pasetti; C. Deantoni; A. Chiara; G. Berardi; A. Briganti; R. Calandrino; C. Cozzarini; C. Fiorino


International Journal of Radiation Oncology Biology Physics | 2009

Factors Predicting Late Severe Urinary Toxicity following Post-operative Irradiation for Prostate Carcinoma: A Single-institution Analysis of 742 Patients

C. Cozzarini; C. Fiorino; F. Alongi; G. Berardi; Angelo Bolognesi; S. Broggi; A.M. Deli; M. Pasetti; Patrizio Rigatti; N. Di Muzio


International Journal of Radiation Oncology Biology Physics | 2009

Feasibility of Tomotherapy for Craniospinal Irradiation

A. del Vecchio; Micaela Motta; Angelo Bolognesi; M. Pasetti; S. Broggi; L. Rigoni; L. Perna; N. Di Muzio


Radiotherapy and Oncology | 2015

PO-0719: Excellent 5 year outcome with image guided moderate hypofractionation in prostate cancer : phase I-II study results

N. Di Muzio; A. Fodor; B. Noris Chiorda; C. Cozzarini; S. Broggi; P. Mangili; Riccardo Valdagni; I. Dell'Oca; M. Pasetti; C. Deantoni; A. Chiara; G. Berardi; A. Briganti; R. Calandrino; C. Fiorino


Radiotherapy and Oncology | 2011

868 poster SIMULTANEOUS INTEGRATED BOOST 18FDG-PET BASED HELICAL TOMOTHERAPY IN RADICAL LOCALLY ADVANCED HEAD AND NECK CANCER.

I. Dell'Oca; C. Fiorino; A. Fodor; A. Chiara; Eugenio Villa; W. Casagrande; Alessia Rognone; M. Pasetti; S. Broggi; Elena Busnardo; Claudio Landoni; Luigi Gianolli; R. Calandrino; N. Di Muzio


Radiotherapy and Oncology | 2018

EP-1390: Salvage (postponed) hypofractionated tomotherapy for progressive MPM in patients with intact lungs

A. Fodor; S. Broggi; Elena Incerti; I. Dell'Oca; C. Fiorino; A.M. Samanes Gajate; P. Passoni; M. Pasetti; Mauro Cattaneo; Luigi Gianolli; R. Calandrino; Maria Picchio; N. Di Muzio


Radiotherapy and Oncology | 2018

EP-1221: Hypoxia imaging with 18F-FAZA PET/CT in Radiotherapy Planning for High Grade Gliomas

F. Zerbetto; Valentino Bettinardi; A.M. Deli; A. Fodor; Paola Mapelli; Elena Incerti; Federico Fallanca; C. Deantoni; M. Pasetti; I. Dell'Oca; A. Chiara; N. Slim; Giacomo Rossi; C. Gumina; Maria Picchio; Angelo Bolognesi; Luigi Gianolli; N. Di Muzio


European Journal of Nuclear Medicine and Molecular Imaging | 2018

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

Elena Incerti; S. Broggi; A. Fodor; M. Cuzzocrea; A.M. Samanes Gajate; Paola Mapelli; C. Fiorino; I. Dell’Oca; M. Pasetti; Mauro Cattaneo; R. Calandrino; Luigi Gianolli; N. Di Muzio; Maria Picchio

Collaboration


Dive into the M. Pasetti's collaboration.

Top Co-Authors

Avatar

C. Fiorino

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

N. Di Muzio

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

A. Fodor

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

R. Calandrino

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

S. Broggi

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

I. Dell'Oca

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

C. Cozzarini

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

A. Chiara

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

P. Mangili

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge